Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
PEPG · NASDAQ · Pharmaceutical Preparations
$3.88−0.31 (−7.40%)
Close of Nov 17, 2026, vs Nov 16 · end-of-day, not a live quote
Pepgen (PEPG) · oqro.io/stocks/PEPG · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
5%+ stake, activist · Stake as of Nov 13, 2026 · Filed Nov 17, 2026
RA Capital Management, L.P. disclosed a 30.5% stake in PEPG and may seek to influence the companySourceInsider trade · Traded Nov 13, 2026 · Filed Nov 17, 2026
Director purchased ~$43.1M of PEPG shares in the open marketSourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Viking Global disclosed an increased position in PEPG for Q3 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Ra Capital Management, L.P. disclosed an increased position in PEPG for Q3 2025SourceInsider trade · Traded Sep 26, 2025 · Filed Sep 30, 2025
Director purchased ~$30M of PEPG shares in the open marketSourceInsider trade · Traded Apr 17, 2025 · Filed Apr 22, 2025
CEO purchased ~$14K of PEPG shares in the open marketSourceInsider trade · Traded Apr 8, 2025 · Filed Apr 9, 2025
CEO purchased ~$48K of PEPG shares in the open marketSourceInsider trade · Traded Feb 26, 2025 · Filed Feb 27, 2025
CFO sold ~$2.6K of PEPG shares in the open marketSourceInsider trade · Traded Feb 26, 2025 · Filed Feb 27, 2025
Officer sold ~$2.4K of PEPG shares in the open marketSourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Perceptive Advisors LLC disclosed a reduced position in PEPG for Q4 2024SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Montanova Capital, LLC disclosed a reduced position in PEPG for Q4 2024SourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 15, 2024
Frazier Life Sciences Management, L.P. disclosed a reduced position in PEPG for Q3 2024SourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
Montanova Capital, LLC disclosed an increased position in PEPG for Q3 2024Source